| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |